Earnings Call · Q2 FY2024·2024-08-14

Q2 24EPS -2.56%·Rev n/aQ1 24EPS +2.56%·Rev n/aQ4 23EPS -59.52%·Rev n/aQ3 23EPS +28.00%·Rev n/a⚠ consensus missing

Invivyd, Inc. IVVD

Katie Falzone — Vice President, Corporate Controller

Marc Elia — Chief Financial Officer

Tim Lee — Chief Executive Officer

Mark Wingertzahn — Chief Medical Officer

Robert Allen — Chief Scientific Officer

Bill Duke — Chief Commercial Officer

−7.5%1d on move date−7.9% vs SPY3d−7.9%5d−18.6%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IVVD calls or request research access.

More IVVD calls Browse calls Request research access